tiprankstipranks
Brainsway Ltd (BWAY)
NASDAQ:BWAY
US Market

Brainsway (BWAY) Earnings Dates, Call Summary & Reports

Compare
271 Followers

Earnings Data

Report Date
Apr 01, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
0.02
Last Year’s EPS
0
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 13, 2018
|
% Change Since: -1.85%
|
Next Earnings Date:Aug 27, 2018
Earnings Call Sentiment|Positive
BrainsWay's earnings call highlighted strong financial performance, including significant revenue growth, a robust cash position bolstered by strategic financing, and positive future guidance. While operating expenses have increased, the company is successfully expanding its global distribution and pursuing promising R&D initiatives. The sentiment of the call is overall positive given the achievements and growth potential despite the mentioned cost increases.
Company Guidance
During the BrainsWay Third Quarter 2024 Earnings Conference Call, the company provided guidance highlighting strong performance and optimistic projections. BrainsWay reported a 26% year-over-year revenue increase to $10.5 million for Q3 and has raised its full-year 2024 revenue guidance to $40-$41 million, reflecting a 26%-29% growth over 2023. Additionally, the company anticipates generating operating income of 3%-4% and adjusted EBITDA of 10%-11% for the full year. The company also emphasized its robust cash position, with approximately $68.4 million post-financing, and outlined plans for strategic investments in R&D, clinical trials, and sales to maintain growth momentum.
Revenue Growth and Financial Performance
BrainsWay reported a 26% year-over-year increase in revenue to $10.5 million for the third quarter of 2024. The company generated positive quarterly net income for the fourth consecutive quarter and positive adjusted EBITDA and cash flow from operations for the fifth consecutive quarter.
Strong Cash Position and Strategic Financing
BrainsWay reported $48.4 million in cash as of September 30, 2024, and completed a strategic private investment equity financing with Valor Equity Partners for approximately $20 million, resulting in a pro forma cash position of approximately $68.4 million.
Guidance and Profitability Outlook
The company increased its full-year 2024 revenue guidance to a range of $40 million to $41 million, representing growth of 26% to 29% over 2023 revenue. It also anticipates generating operating income of 3% to 4% and adjusted EBITDA of 10% to 11% for the full year 2024.
Expansion of Global Distribution
BrainsWay expanded its global distribution and sales network, with placements of 15 new Deep TMS systems in Taiwan and South Korea. The company is also seeking additional regulatory approvals and reimbursement coverage expansions.
R&D and Clinical Trials
The company reported that its multicenter clinical trial for an accelerated treatment protocol for its Deep TMS system to treat major depressive disorder is fully underway.
---

Brainsway (BWAY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BWAY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 27, 20182018 (Q2)
- / -0.22
-0.06-266.67% (-0.16)
Nov 13, 20182018 (Q3)
- / -0.18
-0.2425.83% (+0.06)
Mar 27, 20192018 (Q4)
- / -0.12
-0.3464.71% (+0.22)
May 29, 20192019 (Q1)
- / -0.11
-0.12310.57% (+0.01)
Aug 26, 20192019 (Q2)
- / -0.17
-0.2222.73% (+0.05)
Nov 25, 20192019 (Q3)
- / -0.12
-0.17832.58% (+0.06)
Mar 23, 20202019 (Q4)
- / -0.10
-0.1216.67% (+0.02)
Jun 24, 20202020 (Q1)
- / -0.15
-0.11-36.36% (-0.04)
Aug 12, 20202020 (Q2)
- / -0.03
-0.1782.35% (+0.14)
Nov 18, 20202020 (Q3)
- / -0.04
-0.1266.67% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BWAY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2024$10.80$9.70-10.19%
Aug 06, 2024$6.39$6.89+7.82%
May 08, 2024$6.09$5.70-6.40%
Mar 06, 2024$6.18$6.180.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Brainsway Ltd (BWAY) report earnings?
Brainsway Ltd (BWAY) is schdueled to report earning on Apr 01, 2025, TBA Not Confirmed.
    What is Brainsway Ltd (BWAY) earnings time?
    Brainsway Ltd (BWAY) earnings time is at Apr 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BWAY EPS forecast?
          BWAY EPS forecast for the fiscal quarter 2024 (Q4) is 0.02.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis